AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BCAL DIAGNOSTICS LTD

0.062

+0.01019.23%

Volume:351.03K

Turnover:23.68K

Market Cap:22.82M

PE:-3.11

High:0.070

Open:0.060

Low:0.060

Close:0.052

52wk High:0.155

52wk Low:0.052

Shares:368.07M

Float Shares:202.44M

Volume Ratio:10.41

T/O Rate:0.17%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.020

EPS(LYR):-0.020

ROE:-121.67%

ROA:-46.59%

PB:9.14

PE(LYR):-3.08

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Did Stronger Sales and Quality Shuffle Just Shift Becton Dickinson's (BDX) Investment Narrative?

Simply Wall St.

Becton Dickinson Names Gary Sorsher as Chief Quality Officer

MT Newswires Live

Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says

MT Newswires Live

Becton, Dickinson Completes Enrollment in Trial for Phasix Mesh

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/BDX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BDX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","market":"AU","secType":"STK","nameCN":"BCAL DIAGNOSTICS LTD","latestPrice":0.062,"timestamp":1787724720000,"preClose":0.052,"halted":0,"volume":351027,"delay":0,"changeRate":0.19230769230769235,"nameEN":"BCAL DIAGNOSTICS LTD","floatShares":202437334,"shares":368067640,"eps":-0.01993,"marketStatus":"Closed","change":0.01,"latestTime":"08-26 16:12:00 AEST","open":0.06,"high":0.07,"low":0.06,"amount":23681,"amplitude":0.192308,"askPrice":0.067,"askSize":10000,"bidPrice":0.062,"bidSize":6063,"shortable":3,"etf":0,"ttmEps":-0.01993,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1787788800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.052,"openAndCloseTimeList":[[1787702400000,1787724000000]],"volumeRatio":10.408695,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"BDX.AU","preClose":0.052,"auctionPrice":0.06,"auctionVolume":6450,"auctionTime":1787724010433,"referencePrice":0.062,"referenceTime":1787726520395,"auction":3,"marketStatus":"盘后竞价","timestamp":1787724010433}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"BDX.AU\",,,,,undefined,":{"symbol":"BDX.AU","floatShares":202437334,"roa":"-46.59%","roe":"-121.67%","lyrEps":-0.020136,"volumeRatio":10.408695,"shares":368067640,"dividePrice":0,"high":0.07,"amplitude":0.192308,"preClose":0.052,"low":0.06,"week52Low":0.052,"pbRate":"9.14","psRate":"8.99","week52High":0.155,"institutionHeld":0,"latestPrice":0.062,"committee":-0.245097,"eps":-0.01993,"divideRate":0,"volume":351027,"delay":0,"ttmEps":-0.01993,"open":0.06,"prevYearClose":0.105,"prevWeekClose":0.058,"prevMonthClose":0.067,"prevQuarterClose":0.075,"fiveDayClose":0.056,"twentyDayClose":0.073,"sixtyDayClose":0.078},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BDX.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BDX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BDX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660949476","title":"Did Stronger Sales and Quality Shuffle Just Shift Becton Dickinson's (BDX) Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660949476","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660949476?lang=en_us&edition=fundamental","pubTime":"2026-08-20 05:33","pubTimestamp":1787175181,"startTime":"0","endTime":"0","summary":"Becton, Dickinson and Company recently reported third-quarter fiscal 2026 results showing higher sales of US$4,983,000,000 compared with a year earlier, while net income for both the quarter and year-to-date periods was lower than the prior year.\nAlongside these mixed earnings, BD advanced its tissue regeneration pipeline by fully enrolling the PREVENT trial for Phasix Mesh and reshaped its quality leadership team with the upcoming appointment of Gary Sorsher as chief quality officer and the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/103678-main-header/1756253637694"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/did-stronger-sales-and-quality-shuffle-just-shift-becton-dic","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-bdx/becton-dickinson/news/did-stronger-sales-and-quality-shuffle-just-shift-becton-dic","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BDX.AU","BDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660432145","title":"Becton Dickinson Names Gary Sorsher as Chief Quality Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2660432145","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660432145?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:42","pubTimestamp":1786999370,"startTime":"0","endTime":"0","summary":"Becton Dickinson  has named Gary Sorsher as chief quality officer, effective Sept. 8, the company said late Monday.Sorsher was most recently chief quality officer at Edwards Lifesciences , the company said.Becton Dickinson also said that Jeffrey Silvestri, global head of quality, will retire in October.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BN0W2T93.GBP","IE00BFXG0V08.USD","BK7067","LU0058720904.USD","AGNG","BK4585","IE00BFXG1179.USD","IE00BYQQ9H92.USD","IE00BN0W2W23.USD","LU0130103400.USD","LU1894683264.USD","SGXZ57979304.SGD","BDX.AU","LU0266013472.USD","SG9999001176.SGD","LU1571399168.USD","LU1894683348.USD","BK4504","BK4082","BDX","LU0345774631.USD","LU1150488218.USD","LU0878866978.SGD","LU1854104046.USD","LU0068578508.USD","IE00BN0W2V16.EUR","LU1201861165.SGD","LU0433182093.SGD","LU0823416689.USD","LU0006061336.USD","LU1150488135.SGD","BMED","LU0289739699.SGD","LU0345774391.USD","LU0985489474.SGD","EW","LU0477156797.USD","SG9999013999.USD","LU0289739343.SGD","BK4567","IHI","LU0130518102.USD","LU0985320562.USD","LU0648000940.SGD","LU1489326972.SGD","LU0289961442.SGD","LU1854103824.USD","BK4588","LU0072461881.USD","LU0162691827.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659166809","title":"Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2659166809","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659166809?lang=en_us&edition=fundamental","pubTime":"2026-08-13 23:59","pubTimestamp":1786636784,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  will take 12 to 18 months to have consistent mid-single-digit organic growth as headwinds are expected to persist through fiscal 2027, RBC Capital Markets said in a Thursday note.The company is aiming for a long-term profile of mid-single-digit revenue growth and high-single-digit EPS growth with dividends, RBC analysts said. For fiscal 2027, the management is taking a responsible stance, with revenue growth expected in the low-single digits and modest EPS leverage, according to the note.The analysts said the expected headwinds impacting the company are China, where sales are seen falling to about 3% of revenue in fiscal 2027; its vaccine business, which is down about 30% in the current year but seen stabilizing into the next year; and its Alaris infusion system.RBC is positive on the company's diversified portfolio, BD Excellence program productivity, and commercial momentum across its growth platforms.RBC reiterated the company's stock rating at sector-perform and ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1571399168.USD","LU0878866978.SGD","LU0433182093.SGD","LU0006061336.USD","LU0985489474.SGD","LU0068578508.USD","LU1489326972.SGD","LU0648000940.SGD","LU0289961442.SGD","LU0289739343.SGD","LU0072461881.USD","BK7067","BK4588","LU1201861165.SGD","LU1894683348.USD","LU1059921491.USD","BK4082","BDX.AU","LU0511384066.AUD","LU1854103824.USD","BDX","LU0266013472.USD","IE00BFXG1179.USD","LU0985320562.USD","LU0130103400.USD","IHI","LU1894683264.USD","LU0162691827.USD","LU1854104046.USD","LU0130518102.USD","BK4585","LU0477156797.USD","BK4504","LU1150488218.USD","LU1150488135.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974933","title":"Becton, Dickinson Completes Enrollment in Trial for Phasix Mesh","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974933","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974933?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:31","pubTimestamp":1786534268,"startTime":"0","endTime":"0","summary":"Becton, Dickinson  said Wednesday it completed enrollment in a trial evaluating Phasix Mesh for preventing incisional hernias.The company said the study enrolled 477 patients across 32 sites in the US and Europe and will evaluate the use of resorbable mesh to prevent incisional hernias.Patients will be followed through the trial's primary endpoint at 24 months, with longer-term follow-up planned for five years, the company said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0477156797.USD","LU0006061336.USD","LU0648000940.SGD","LU0130103400.USD","LU1201861165.SGD","LU0266013472.USD","IHI","LU1150488218.USD","BK7067","BDX","LU0289961442.SGD","LU1571399168.USD","LU1854103824.USD","BK4588","LU1150488135.SGD","LU0162691827.USD","BDX.AU","LU0433182093.SGD","LU0878866978.SGD","BK4082","LU0289739343.SGD","LU1894683348.USD","LU0130518102.USD","LU0985489474.SGD","IE00BFXG1179.USD","LU1854104046.USD","LU1059921491.USD","LU0068578508.USD","LU1894683264.USD","BK4585","BK4504","LU0072461881.USD","LU0511384066.AUD","LU1489326972.SGD","LU0985320562.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":12,"pageCount":1,"totalSize":48,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/BDX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}